Bank of Montreal’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$878K Sell
8,451
-3,408
-29% -$363K ﹤0.01% 2108
2025
Q4
$1.22M Buy
11,859
+2,173
+22% +$211K ﹤0.01% 1875
2025
Q3
$875K Sell
9,686
-1,712
-15% -$150K ﹤0.01% 2009
2025
Q2
$1M Sell
11,398
-4,190
-27% -$363K ﹤0.01% 1903
2025
Q1
$1.42M Sell
15,588
-6,989
-31% -$629K ﹤0.01% 1659
2024
Q4
$1.95M Buy
22,577
+937
+4% +$84.8K ﹤0.01% 1562
2024
Q3
$2.05M Buy
21,640
+6,570
+44% +$624K ﹤0.01% 1686
2024
Q2
$1.41M Buy
15,070
+11,500
+322% +$1.03M ﹤0.01% 1844
2024
Q1
$325K Buy
3,570
+305
+9% +$26.7K ﹤0.01% 2728
2023
Q4
$266K Buy
3,265
+125
+4% +$9.8K ﹤0.01% 2948
2023
Q3
$260K Sell
3,140
-11,130
-78% -$897K ﹤0.01% 2910
2023
Q2
$1.13M Buy
14,270
+8,570
+150% +$671K ﹤0.01% 2123
2023
Q1
$442K Sell
5,700
-1,802
-24% -$139K ﹤0.01% 2530
2022
Q4
$585K Sell
7,502
-1,942
-21% -$143K ﹤0.01% 2523
2022
Q3
$666 Buy
9,444
+7,541
+396% +$555K ﹤0.01% 2409
2022
Q2
$150 Sell
1,903
-100
-5% -$7.81K ﹤0.01% 3363
2022
Q1
$161K Sell
2,003
-115
-5% -$8.8K ﹤0.01% 3534
2021
Q4
$165K Buy
2,118
+99
+5% +$7.36K ﹤0.01% 3006
2021
Q3
$148K Hold
2,019
﹤0.01% 3381
2021
Q2
$148K Buy
2,019
+219
+12% +$15.6K ﹤0.01% 3270
2021
Q1
$122K Hold
1,800
﹤0.01% 3313
2020
Q4
$124K Sell
1,800
-400
-18% -$25.6K ﹤0.01% 3476
2020
Q3
$135K Hold
2,200
﹤0.01% 2927
2020
Q2
$135K Sell
2,200
-300
-12% -$18.1K ﹤0.01% 2934
2020
Q1
$132K Sell
2,500
-700
-22% -$43.1K ﹤0.01% 2491
2019
Q4
$205K Sell
3,200
-150
-4% -$9.04K ﹤0.01% 3150
2019
Q3
$191K Buy
3,350
+140
+4% +$8.02K ﹤0.01% 2935
2019
Q2
$188K Buy
3,210
+100
+3% +$5.79K ﹤0.01% 2956
2019
Q1
$189K Buy
3,110
+400
+15% +$23.6K ﹤0.01% 2750
2018
Q4
$148K Hold
2,710
﹤0.01% 2738
2018
Q3
$174K Hold
2,710
﹤0.01% 2825
2018
Q2
$160K Sell
2,710
-194
-7% -$11.2K ﹤0.01% 2875
2018
Q1
$165K Hold
2,904
﹤0.01% 2720
2017
Q4
$172K Sell
2,904
-90
-3% -$5.16K ﹤0.01% 2745
2017
Q3
$173K Buy
2,994
+144
+5% +$8.18K ﹤0.01% 2726
2017
Q2
$168K Sell
2,850
-100
-3% -$5.66K ﹤0.01% 2741
2017
Q1
$163K Hold
2,950
﹤0.01% 2585
2016
Q4
$153K Hold
2,950
﹤0.01% 2625
2016
Q3
$170K Hold
2,950
﹤0.01% 2516
2016
Q2
$173K Sell
2,950
-100
-3% -$5.83K ﹤0.01% 2542
2016
Q1
$175K Sell
3,050
-300
-9% -$17.7K ﹤0.01% 2538
2015
Q4
$219K Sell
3,350
-1,300
-28% -$84K ﹤0.01% 2377
2015
Q3
$293K Sell
4,650
-100
-2% -$7.03K ﹤0.01% 2085
2015
Q2
$336K Sell
4,750
-200
-4% -$14.4K ﹤0.01% 2170
2015
Q1
$348K Sell
4,950
-200
-4% -$13.6K ﹤0.01% 2119
2014
Q4
$331K Sell
5,150
-400
-7% -$25.5K ﹤0.01% 2250
2014
Q3
$353K Buy
5,550
+400
+8% +$24.8K ﹤0.01% 2260
2014
Q2
$320K Sell
5,150
-300
-6% -$17.8K ﹤0.01% 2307
2014
Q1
$318K Sell
5,450
-3,555
-39% -$201K ﹤0.01% 2296
2013
Q4
$479K Buy
9,005
+700
+8% +$35.4K ﹤0.01% 1836
2013
Q3
$397K Sell
8,305
-200
-2% -$9.48K ﹤0.01% 1916
2013
Q2
$387K Buy
+8,505
New +$393K ﹤0.01% 1871

Other funds holding PPH

Bank of Montreal's PPH Position: Q1 2026 in Review

Bank of Montreal reduced its VanEck Pharmaceutical ETF (PPH) stake by 29% in Q1 2026, selling an estimated $363K and leaving 8,451 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

Bank of Montreal first reported a position in PPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.05M in Q3 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Bank of Montreal held 8,451 shares of VanEck Pharmaceutical ETF worth $878K as of Q1 2026.
  • Bank of Montreal sold 3,408 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $363K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2108 holding.
  • Bank of Montreal first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's VanEck Pharmaceutical ETF position peaked at $2.05M in Q3 2024.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.